Lv2
118 积分 2023-10-27 加入
P1114 Engineering and Development of a Novel Bispecific Antibody Targeting IL-23 and TL1A
5个月前
已完结
Complement regulators as novel targets for anti-cancer therapy: A comprehensive review
8个月前
已完结
ICW – 2021 Virtual Workshop of the International Complement Society (ICS) – Abstracts; December 07 – 10, 2021
9个月前
已完结
皖公网安备34019202002308
